Benitec Biopharma Inc. (BNTC) Earnings History
Annual and quarterly earnings data from 2013 to 2025
Loading earnings history...
BNTC EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
BNTC Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | -408.0% | -25441.3% | -26082.7% |
| 2022 | 87.7% | -24457.5% | -24942.5% |
| 2021 | -108.5% | -23044.1% | -23528.8% |
Download Data
Export BNTC earnings history in CSV or JSON format
Free sign-in required to download data
Benitec Biopharma Inc. (BNTC) Earnings Overview
As of May 8, 2026, Benitec Biopharma Inc. (BNTC) reported trailing twelve-month net income of -$51M, reflecting +60.8% year-over-year growth. The company earned $-1.11 per diluted share over the past four quarters.
Looking at the long-term picture, BNTC's historical earnings data spans multiple years. The company achieved its highest annual net income of $3M in fiscal 2019.
Benitec Biopharma Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including KRYS ($225M net income, 52.6% margin), RCKT (-$223M net income), QURE (-$209M net income, -1236.0% margin), BNTC has comparable earnings metrics. Compare BNTC vs KRYS →
BNTC Earnings vs Peers
Earnings metrics vs comparable public companies
BNTC Historical Earnings Data (2013–2025)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$38M | -74.3% | -$42M | $-1.05 | - | - |
| 2024 | -$22M | -11.2% | -$23M | $-2.68 | - | - |
| 2023 | -$20M | -7.4% | -$19M | $-14.12 | -26082.7% | -25441.3% |
| 2022 | -$18M | -31.2% | -$18M | $-19.31 | -24942.5% | -24457.5% |
| 2021 | -$14M | -67.8% | -$14M | $-27.27 | -23528.8% | -23044.1% |
| 2020 | -$8M | -388.6% | -$8M | $-69.09 | -8529.9% | -8537.1% |
| 2019 | $3M | +133.5% | $2M | $28.45 | 25.3% | 17.7% |
| 2018 | -$9M | -95.6% | -$9M | $-103.61 | -1877.4% | -1877.7% |
| 2017 | -$4M | +76.4% | -$16M | $-63.55 | -971.0% | -3536.2% |
| 2016 | -$19M | -109.6% | -$25M | $-331.56 | -5340.1% | -7204.2% |
See BNTC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BNTC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BNTC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBNTC — Frequently Asked Questions
Quick answers to the most common questions about buying BNTC stock.
Is BNTC growing earnings?
BNTC EPS is $-1.11, with earnings growth accelerating to +60.8%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-51M.
What are BNTC's profit margins?
Benitec Biopharma Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are BNTC's earnings?
BNTC earnings data spans 2013-2025. The accelerating earnings trend is +60.8% YoY. Historical data enables comparison across business cycles.